Pathways Related to NLRP3 Inflammasome Activation Induced by Gold Nanorods. 2022

Rob J Vandebriel, and Sylvie Remy, and Jolanda P Vermeulen, and Evelien G E Hurkmans, and Kirsten Kevenaar, and Neus G Bastús, and Beatriz Pelaz, and Mahmoud G Soliman, and Victor F Puntes, and Wolfgang J Parak, and Jeroen L A Pennings, and Inge Nelissen
Centre for Health Protection, National Institute for Public Health & the Environment, 3720 BA Bilthoven, The Netherlands.

The widespread and increasing use of engineered nanomaterials (ENM) increases the risk of human exposure, generating concern that ENM may provoke adverse health effects. In this respect, their physicochemical characteristics are critical. The immune system may respond to ENM through inflammatory reactions. The NLRP3 inflammasome responds to a wide range of ENM, and its activation is associated with various inflammatory diseases. Recently, anisotropic ENM have become of increasing interest, but knowledge of their effects on the immune system is still limited. The objective of the study was to compare the effects of gold ENM of different shapes on NLRP3 inflammasome activation and related signalling pathways. Differentiated THP-1 cells (wildtype, ASC- or NLRP3-deficient), were exposed to PEGylated gold nanorods, nanostars, and nanospheres, and, thus, also different surface chemistries, to assess NLRP3 inflammasome activation. Next, the exposed cells were subjected to gene expression analysis. Nanorods, but not nanostars or nanospheres, showed NLRP3 inflammasome activation. ASC- or NLRP3-deficient cells did not show this effect. Gene Set Enrichment Analysis revealed that gold nanorod-induced NLRP3 inflammasome activation was accompanied by downregulated sterol/cholesterol biosynthesis, oxidative phosphorylation, and purinergic receptor signalling. At the level of individual genes, downregulation of Paraoxonase-2, a protein that controls oxidative stress, was most notable. In conclusion, the shape and surface chemistry of gold nanoparticles determine NLRP3 inflammasome activation. Future studies should include particle uptake and intracellular localization.

UI MeSH Term Description Entries
D006046 Gold A yellow metallic element with the atomic symbol Au, atomic number 79, and atomic weight 197. It is used in jewelry, goldplating of other metals, as currency, and in dental restoration. Many of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071199 NLR Family, Pyrin Domain-Containing 3 Protein An NLR protein that contains an N-terminal PYRIN DOMAIN and ATP-binding site and 9 C-terminal LEUCINE-rich repeats; it is expressed primarily by MACROPHAGES. It is a core component of the INFLAMMASOME and directs its assembly in response to pathogen infection and damage-associated stimuli. Mutations in the NLRP3 gene are associated with FAMILIAL COLD AUTOINFLAMMATORY SYNDROME. Cold Autoinflammatory Syndrome 1 Protein,NACHT, LRR and PYD Domains-Containing Protein 3,NLRP3 Protein,NACHT, LRR and PYD Domains Containing Protein 3,NLR Family, Pyrin Domain Containing 3 Protein
D043942 Nanotubes Nanometer-sized tubes composed of various substances including carbon (CARBON NANOTUBES), boron nitride, or nickel vanadate. Nanorods,Nanorod,Nanotube
D053768 Metal Nanoparticles Nanoparticles produced from metals whose uses include biosensors, optics, and catalysts. In biomedical applications the particles frequently involve the noble metals, especially gold and silver. Metal Nanocrystals,Metallic Nanocrystals,Metallic Nanoparticles,Metal Nanocrystal,Metal Nanoparticle,Metallic Nanocrystal,Metallic Nanoparticle,Nanocrystal, Metal,Nanocrystal, Metallic,Nanocrystals, Metal,Nanocrystals, Metallic,Nanoparticle, Metal,Nanoparticle, Metallic,Nanoparticles, Metal,Nanoparticles, Metallic
D058847 Inflammasomes Multiprotein complexes that mediate the activation of CASPASE-1. Dysregulation of inflammasomes has also been linked to a number of autoinflammatory and autoimmune disorders. Inflammasome,Pyroptosome,Pyroptosomes

Related Publications

Rob J Vandebriel, and Sylvie Remy, and Jolanda P Vermeulen, and Evelien G E Hurkmans, and Kirsten Kevenaar, and Neus G Bastús, and Beatriz Pelaz, and Mahmoud G Soliman, and Victor F Puntes, and Wolfgang J Parak, and Jeroen L A Pennings, and Inge Nelissen
November 2022, Nanomaterials (Basel, Switzerland),
Rob J Vandebriel, and Sylvie Remy, and Jolanda P Vermeulen, and Evelien G E Hurkmans, and Kirsten Kevenaar, and Neus G Bastús, and Beatriz Pelaz, and Mahmoud G Soliman, and Victor F Puntes, and Wolfgang J Parak, and Jeroen L A Pennings, and Inge Nelissen
May 2013, Small (Weinheim an der Bergstrasse, Germany),
Rob J Vandebriel, and Sylvie Remy, and Jolanda P Vermeulen, and Evelien G E Hurkmans, and Kirsten Kevenaar, and Neus G Bastús, and Beatriz Pelaz, and Mahmoud G Soliman, and Victor F Puntes, and Wolfgang J Parak, and Jeroen L A Pennings, and Inge Nelissen
August 2021, Inflammation,
Rob J Vandebriel, and Sylvie Remy, and Jolanda P Vermeulen, and Evelien G E Hurkmans, and Kirsten Kevenaar, and Neus G Bastús, and Beatriz Pelaz, and Mahmoud G Soliman, and Victor F Puntes, and Wolfgang J Parak, and Jeroen L A Pennings, and Inge Nelissen
January 2013, Methods in molecular biology (Clifton, N.J.),
Rob J Vandebriel, and Sylvie Remy, and Jolanda P Vermeulen, and Evelien G E Hurkmans, and Kirsten Kevenaar, and Neus G Bastús, and Beatriz Pelaz, and Mahmoud G Soliman, and Victor F Puntes, and Wolfgang J Parak, and Jeroen L A Pennings, and Inge Nelissen
January 2021, Frontiers in immunology,
Rob J Vandebriel, and Sylvie Remy, and Jolanda P Vermeulen, and Evelien G E Hurkmans, and Kirsten Kevenaar, and Neus G Bastús, and Beatriz Pelaz, and Mahmoud G Soliman, and Victor F Puntes, and Wolfgang J Parak, and Jeroen L A Pennings, and Inge Nelissen
September 2019, Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology,
Rob J Vandebriel, and Sylvie Remy, and Jolanda P Vermeulen, and Evelien G E Hurkmans, and Kirsten Kevenaar, and Neus G Bastús, and Beatriz Pelaz, and Mahmoud G Soliman, and Victor F Puntes, and Wolfgang J Parak, and Jeroen L A Pennings, and Inge Nelissen
April 2017, American journal of physiology. Renal physiology,
Rob J Vandebriel, and Sylvie Remy, and Jolanda P Vermeulen, and Evelien G E Hurkmans, and Kirsten Kevenaar, and Neus G Bastús, and Beatriz Pelaz, and Mahmoud G Soliman, and Victor F Puntes, and Wolfgang J Parak, and Jeroen L A Pennings, and Inge Nelissen
March 2023, International immunopharmacology,
Rob J Vandebriel, and Sylvie Remy, and Jolanda P Vermeulen, and Evelien G E Hurkmans, and Kirsten Kevenaar, and Neus G Bastús, and Beatriz Pelaz, and Mahmoud G Soliman, and Victor F Puntes, and Wolfgang J Parak, and Jeroen L A Pennings, and Inge Nelissen
January 2018, Methods in molecular biology (Clifton, N.J.),
Rob J Vandebriel, and Sylvie Remy, and Jolanda P Vermeulen, and Evelien G E Hurkmans, and Kirsten Kevenaar, and Neus G Bastús, and Beatriz Pelaz, and Mahmoud G Soliman, and Victor F Puntes, and Wolfgang J Parak, and Jeroen L A Pennings, and Inge Nelissen
January 2013, PLoS neglected tropical diseases,
Copied contents to your clipboard!